Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A genomic and epigenomic lens into the biology of acute lymphoblastic leukaemia.

Nature reviews. Cancer·2026
Same author

FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.

Leukemia·2026
Same author

Condensates in fusion oncoprotein-driven leukemia: new biology and therapeutic opportunities.

Trends in cancer·2026
Same author

Long-term Follow-up of a Pediatric Regimen for AYA with Ph-negative ALL: 10-year Survival of CALGB 10403 (Alliance).

Blood advances·2026
Same author

Characterization of Genetic Etiologic Factors for Pediatric Acute Lymphoblastic Leukemia in Large Childhood Cancer Survivorship Cohorts.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Genomic Insights into the Biology of T-lineage Acute Lymphoblastic Leukemia.

Blood cancer discovery·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: May 13, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

急性リンパ性白血病 (Acute Lymphoblastic Leukemia) とは,急性リンパ性白血病 (Acute Lymphoblastic Leukemia) とは,急性リンパ性白血病 (Acute

Hiroto Inaba1, Mel Greaves, Charles G Mullighan

  • 1Department of Oncology, St Jude Children's Research Hospital and University of Tennessee Health Science Center, Memphis, TN 38105, USA. hiroto.inaba@stjude.org

Lancet (London, England)
|March 26, 2013
PubMed
まとめ
この要約は機械生成です。

幼児期急性リンパ性白血病の生存率は現在90%ですが,乳幼児と成人のアウトカムを改善するために,新しい遺伝的洞察が不可欠です. パーソナライズド医療は,より良い治療法と副作用の減少への希望を提供します.

さらに関連する動画

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining
06:41

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Published on: July 19, 2024

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

関連する実験動画

Last Updated: May 13, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining
06:41

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Published on: July 19, 2024

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

科学分野:

  • 腫瘍学 腫瘍学
  • 遺伝学 遺伝学とは
  • 小児血液学/腫瘍学

背景:

  • 急性リンパ性白血病 (ALL) は,多因的な原因を持つ一般的な小児がんです.
  • 小児ALLの生存率は著しく改善され,臨床試験では約90%に達しています.
  • しかし,L.A.L.を患っている乳児と成人の予後は依然として不良であり,革新的な治療戦略が必要である.

研究 の 目的:

  • ALLの病原性,治療の進歩,および将来の方向性に関する現在の理解をレビューする.
  • 新しいサブタイプと治療目標の特定における遺伝子プロファイルの役割を強調する.
  • 生存率を向上させ,特に高リスク集団における有害な影響を軽減するための新しいアプローチの必要性を強調する.

主な方法:

  • 急性リンパ性白血病の疫学,治療,遺伝学に関する既存の文献のレビュー.
  • 小児ALLにおける生存データとリスク分層化戦略の分析.
  • 白血病細胞の遺伝子変異を特定するための全ゲノムプロファイリング技術についての議論.

主要な成果:

  • 小児ALL生存率は,リスクの階層化,パーソナライズされた治療改定 (薬物動力学および薬物遺伝学),および強化されたサポートケアにより改善されています.
  • ゲノム全体のDNAプロファイリングは,白血病発生に寄与し,新しい疾患サブタイプを定義する新しい遺伝的変化を明らかにしました.
  • これらの遺伝的発見は,パーソナライズされた医療のための潜在的な予後マーカーと治療目標を提供します.

結論:

  • 小児ALLの生存率は高いが,特に乳児と成人の場合はさらなる進歩が必要である.
  • 遺伝子プロファイリングは,ALLの複雑性を理解し,ターゲットを絞った治療法を開発するのに不可欠です.
  • パーソナライズド医療のアプローチは,ALL治療における結果を改善し,毒性を最小限に抑えることを約束しています.